Efficacy and safety of thalidomide in patients with inflammatory manifestations of chronic granulomatous disease: a retrospective case series

J Allergy Clin Immunol. 2013 Oct;132(4):997-1000.e1-4. doi: 10.1016/j.jaci.2013.04.059. Epub 2013 Jun 20.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Female
  • Granulomatous Disease, Chronic / drug therapy*
  • Granulomatous Disease, Chronic / immunology
  • Granulomatous Disease, Chronic / physiopathology
  • Humans
  • Immunosuppressive Agents* / administration & dosage
  • Immunosuppressive Agents* / adverse effects
  • Immunosuppressive Agents* / therapeutic use
  • Infant
  • Inflammation / drug therapy
  • Inflammation / immunology
  • Inflammation / physiopathology
  • Male
  • Retrospective Studies
  • Thalidomide* / administration & dosage
  • Thalidomide* / adverse effects
  • Thalidomide* / therapeutic use
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Thalidomide